Navigation Links
Genomic surveillance of pandemic H1N1
Date:1/21/2010

VANCOUVER, B.C. The BC Centre for Disease Control has launched an influenza genome sequencing project to better understand how the pandemic H1N1 flu virus has evolved in British Columbia, and may continue to evolve in the coming months.

This project capitalizes on BC's expertise and capacity in genome sequencing to generate hundreds of complete genomes from circulating influenza viruses collected in British Columbia during the H1N1 pandemic, as well as during and after the Olympics. By comparing the evolution of BC's influenza virus to that of viruses sequenced in other regions, researchers hope to learn how a mass gathering such as the Olympics can impact the virus' genetic sequence. The project will also allow researchers to track the geographic origins of the H1N1 virus that entered BC in 2009.

"We know from earlier studies that one of the most important drivers of an influenza virus' evolution is the mixing of different lineages of virus from around the world," explains Dr. Robert Brunham, Provincial Executive Director of the BC Centre for Disease Control. "While we are not expecting a third wave of H1N1 in BC, we will have over 250,000 visitors in Vancouver in February, which may impact influenza virus evolution."

Although researchers predict that exposure to influenza viruses from different countries will lead to changes in the H1N1 virus' genetic sequence, these changes are unlikely to change the severity of disease due to the H1N1 virus.

"The data uncovered from this project will enable BC to track how the virus moved through the population - information that can assist public health officials in understanding the virus and preparing for future outbreaks," explains Dr. Perry Kendall, British Columbia's Provincial Health Officer.

Large-scale genome projects such as this have only become common in the last five years, as sequencing technologies have improved and become faster and more cost-efficient. "This is the first time since this technology has matured that both a pandemic and an Olympics have occurred together," says Dr. Alan Winter, President and CEO of Genome BC. "The timing provides a very significant opportunity to study how a virus evolves when it is meeting and mixing with viruses from around the world."

While influenza activity has declined to baseline or below baseline levels in Canada, pandemic H1N1 activity elsewhere remains variable, with some Eastern European and Western Asian countries continuing to report above-baseline activity levels.

This project is jointly funded by the BC Centre for Disease Control, Genome British Columbia and Genome Canada. Research is being conducted at both the BCCDC Public Health Microbiology & Reference Laboratory and Canada's Michael Smith Genome Sciences Centre.


'/>"/>

Contact: Gabrielle Nye
604-790-0034
Genome BC
Source:Eurekalert

Related medicine news :

1. The Institut Curie and Ipsogen Sign a Scientific Collaboration Agreement Relating to the Genomic Grade, a Molecular Diagnostic Tool for Breast Cancer
2. NeoGenomics Announces Executive Appointments
3. Genomic Health to Present Five New Studies at 32nd Annual San Antonio Breast Cancer Symposium
4. Genomic Health Announces Third Quarter 2009 Financial Results and Business Progress
5. Will genomics help prevent the next pandemic?
6. Genomic Health Announces Data Confirming Manual Microdissection of Biopsy Cavities Is Essential for Accurate Recurrence Risk Assessment in Early-Stage Breast Cancer Patients
7. Genomic Health to Present at the JMP Securities Healthcare Focus Conference
8. Genomic Health to Present at Two Upcoming Investor Conferences
9. Beckman Coulter Announces the Creation of Beckman Coulter Genomics
10. Genomic Health to Present at Canaccord Adams 29th Annual Global Growth Conference
11. GenVaults GenSolve(TM) Reagents Enable State-of-the-Art Genomic Analysis of Dried Blood Spots
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the ... AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in ... topics including advance care planning, healthcare costs and patient and family engagement. , ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library ... City Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ... for fumigation is not a common occurrence, but a necessary one in the event that ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room ... Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the ... In terms of the latter, setting the bar too high can result in disappointment, ... just slow progress toward their goal. , Research from PsychTests.com reveals ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... HILLS, Calif. , June 23, 2016 Any ... the many challenges of the current process. Many of them ... because of the technical difficulties and high laboratory costs involved. ... have to offer it at such a high cost that ... afford it. Dr. Parsa Zadeh , founder ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Issue 52" report to their offering. ... treatment creates a favourable commercial environment for MedImmune to enter. ... base that will serve to drive considerable growth for effective ... serve to cap sales considerably, but development is still in ...
Breaking Medicine Technology: